
Kou Qin, PhD - Eisai Innovation Inc | LinkedIn
Experience: Eisai Innovation Inc · Education: Harvard University · Location: Cambridge · 500+ connections on LinkedIn. View Kou Qin, PhD’s profile on LinkedIn, a professional community of 1...
Eisai Innovation, Inc.
Kou Qin joined Eisai Innovation, Inc. in 2021. Previously at MSA Capital, he was in charge of healthcare strategy and investment globally. Prior to that, he ran the corporate incubation program at BGI. He started Skinome, a skin disease diagnosis company, invested by Y …
Kou QIN | Investor | Venture Capital | Research profile
G protein-coupled receptors (GPCRs) interact directly with heterotrimeric G proteins to transduce physiological signals. Early studies of this interaction concluded that GPCRs (R) and G proteins...
Eisai Innovation investment portfolio | PitchBook
Founded in 2019, Eisai Innovation is a corporate venture capital investmen arm of Eisai based in Cambridge, Massachusetts. The firm seeks to invest in the neurology, oncology, diagnostics, …
Kou Qin's Investing Profile - Eisai Innovation, Inc. Investor | Signal
View who can give you a warm intro to Kou and 30,000+ top startup investors by joining Signal. See Kou Qin's recent investments in Seed Medical Devices, other investment areas, and co-investors.
New landmark for art opens in Beijing - China - Chinadaily.com.cn
2017年9月29日 · Kou Qin, general manager of Guardian Art Center and director of China Guardian, says the opening of the art center is China Guardian's attempt to diversify its art business to attract museums, art dealers, artists and art lovers, instead of only art buyers. "It shows our confidence in China's art market and cultural scene.
Kou Qin, PhD on LinkedIn: Runners-Up
Science magazine's Breakthroughs of the Year: both the GLP-1 agonist for obesity treatment and the anti-Abeta antibody lecanemab for Alzheimer's disease have…
ArtPro Exclusive Interview with Kou Qin, A Symbiotic and Win-win ...
Here, ArtPro Exclusive Interview with Kou Qin, who is the Managing Director of Guardian Investment and General Manager of Guardian Art Center, conducted a series of discussions on "three changes of Guardian Art Week (GFAA)", "three criteria for selecting exhibitors" and "in what kind of soil did Guardian Art Week (GFAA) grow up".
Kou Qin, PhD | LinkedIn
Check out professional insights posted by Kou Qin, PhD, Investment Director @ Eisai Innovation | Biotech Venture Capitalist
Kou Qin - The Information
Investment Director | Eisai Innovation Inc | Corporate VC of Eisai
- 某些结果已被删除